Pfizer: 5 more countries OK arthritis pill Xeljanz

TRENTON, New Jersey (AP) — Several more countries have approved Pfizer Inc.'s new rheumatoid arthritis medicine, a twice-a-day pill seen as likely to be a big moneymaker for the company.